%0 Journal Article
%T Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report
%A Ariadna Balada
%A Clara Mayo de las Casas
%A Cristina Teixid¨®
%A Daniela Morales-Espinosa
%A Maria Gonzalez-Cao
%A Miguel ¨¢ngel Molina-Vila
%A M¨®nica Garz¨®n
%A Niki Karachaliou
%A Nuria Jordana Ariza
%A Rafael Rosell
%A Santiago Viteri Ramirez
%J SCIE-indexed Journal
%D 2016
%X Activating mutations in the epidermal growth factor receptor (EGFR) gene are the first validated biomarker to predict significant progression-free survival (PFS) benefit with treatment with EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) (1-5)
%U http://tlcr.amegroups.com/article/view/10202/8676